ZYUS LIFE SCIENCES CORPORATION

Insiders ZYUS Life Sciences Corporation

Equities

ZYUS

CA9899601095

Delayed Toronto S.E. Other stock markets 09:30:00 2024-06-26 EDT			5-day change	1st Jan Change
1.05 ^CAD	+3.96%		+3.96%	+16.67%

06-04	ZYUS Life Sciences Corp. Brief: Says Cannabis Drug License Enables It to Expand its Clinical Research Activities by Manufacturing Drugs Containing Cannabis in Canada	MT
06-04	ZYUS Life Sciences Corp. Brief: Lost 4.6% on Monday, But Today Said It Received Cannabis Drug License from Health Canada	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ZYUS Life Sciences Appoints Dr. Hance Clarke to Clinical Advisory Committee	02-01	MT
Zyus Appoints Dr. Hance Clarke as Clinical Advisory Committee	02-01	CI
ZYUS Life Sciences Corporation Appoints Tim Miller as Director of Investor Relations and Capital Markets, Effective November 1, 2023	23-10-24	CI
ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member, Wayne Brownlee and Announces Reconstitution of its Board Committees	23-08-31	CI
ZYUS Life Sciences Corporation Strengthens Board of Directors with the Appointment of Wayne Brownlee	23-06-29	CI
Phoenix Canada Oil Company Limited Announces Addition to Advisory Board	15-12-30	CI
Phoenix Canada Oil Co. Ltd. Announces Management Changes	15-08-20	CI
Phoenix Canada Oil Company Limited Announces Death of S. Donald Moore, President, Chief Executive Officer and Chairman	15-08-11	CI
Phoenix Canada Oil Company Limited Appoints Michael D. Kindy as Chief Financial Officer	15-04-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer